Meeting
2016 Genitourinary Cancers Symposium
Actionable targets in patients with cisplatin-resistant advanced germ cell tumors.
Authors
Aditya Bagrodia
Memorial Sloan Kettering Cancer Center, New York, NY
Aditya Bagrodia , Samuel D. Kaffenberger , Byron Lee , William Lee , Eugene K. Cha , John Sfakianos , Sizhi Paul Gao , Emily Craig Zabor , Irina Ostrovnaya , Jana Eng , Michael F. Berger , Dean F. Bajorin , Nikolaus Schultz , Joel Sheinfeld , George J. Bosl , Hikmat Al-Ahmadie , David B. Solit , Darren R. Feldman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, and Testicular Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Penile, Urethral, and Testicular Cancers
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 473)
DOI
10.1200/jco.2016.34.2_suppl.473
Abstract #
473
Poster Bd #
B7
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Parallel sequencing of a 50 genes panel in metastatic colorectal cancer (MCRC) patients (pts) treated with intensive first-line FIr-B/FOx triplet chemotherapy plus bevacizumab (BEV): Preliminary data and clinical outcome.
First Author: Gemma Bruera
Poster
2020 Genitourinary Cancers Symposium
Genomic analysis for potential targetable mutations in relapsed and refractory germ cell tumors.
First Author: Sean Q. Kern
Poster
2015 ASCO Annual Meeting
Comprehensive genomic profiling of clinically advanced colorectal carcinoma to reveal frequent opportunities for targeted therapies.
First Author: Jeffrey S. Ross
Poster
2014 ASCO Annual Meeting
Tumor genomic mutation profiling of germ cell tumors using “Profile”.
First Author: Elizabeth O'Donnell